Skip to content

Opening book details…

Can I read Human Wharton’s jelly mesenchymal stem cells derived-exosomes enriched by miR-124 promote an anti-fibrotic response in an experimental model of liver fibrosis on EtoBox?

Human Wharton’s jelly mesenchymal stem cells derived-exosomes enriched by miR-124 promote an anti-fibrotic response in an experimental model of liver fibrosis by Bahare Niknam; Kaveh Baghaei; Seyed Mahmoud Hashemi; Behzad Hatami; Mohammad Reza Zali; Davar Amani is a Immunology and Microbiology article available to read on EtoBox.

What is Human Wharton’s jelly mesenchymal stem cells derived-exosomes enriched by miR-124 promote an anti-fibrotic response in an experimental model of liver fibrosis about?

Background: Liver fibrosis is a significant challenge to global health that results in organ failure through inflammation and the release of fibrotic biomarkers. Due to the lack of effective treatments for liver fibrosis, antifibrotic and anti-inflammatory therapies are being developed. Since there has been an association between aberrant expression of miR-124 and liver disease progression, we investigated whether delivery of miR-124 through human Wharton's jelly mesenchymal stem cells derived-exosomes (hWJMSC-Exo) can improve liver fibrosis. Methods: We established a 6-week carbon tetrachloride (CCl4)-induced mouse model of liver fibrosis, then we administered hWJMSC-Exo and miR-124-3p-enriched exosomes (ExomiR-124) for three weeks. The extent of fibrosis and inflammation was assessed by histology, biochemistry, Real-time PCR, immunohistochemistry, and Enzyme-linked immunoassays (ELISA). The inflammatory status of the spleen was also investigated using flow cytometry. Results: Based on the gene and protein expression measurement of IL-6, IL-17, TGF-β, STAT3, α-SMA, and COL1, In vivo administration of Exo and ExomiR-124 effectively reduce collagen accumulation and inhibition of inf

Who reads Human Wharton’s jelly mesenchymal stem cells derived-exosomes enriched by miR-124 promote an anti-fibrotic response in an experimental model of liver fibrosis?

It is typically read by researchers, students, and practitioners in Immunology and Microbiology.

Author
Bahare Niknam; Kaveh Baghaei; Seyed Mahmoud Hashemi; Behzad Hatami; Mohammad Reza Zali; Davar Amani
Publisher
Elsevier BV
Published
2023
Language
EN
Field
Immunology and Microbiology (Life Sciences)

More by Bahare Niknam; Kaveh Baghaei; Seyed Mahmoud Hashemi; Behzad Hatami; Mohammad Reza Zali; Davar Amani

Browse all works by Bahare Niknam; Kaveh Baghaei; Seyed Mahmoud Hashemi; Behzad Hatami; Mohammad Reza Zali; Davar Amani